Genome-wide association data reveals a shared genetic foundation between schizophrenia and the use of specific prescription medications.

The FDA has approved Orzeyful (oveporexton), a first-in-class oral orexin receptor 2 agonist, for the treatment of adult narcolepsy type 1.

FDA grants Fast Track designation to PVX108, a novel peptide immunotherapy for peanut allergy, supported by phase 1 data and an ongoing phase 2 pediatric trial.

A new data-driven process may help identify patients that can be served safely while seated in the emergency department.

As autism therapy utilization and spending expand rapidly, federal agencies are pushing for state oversight to manage Medicaid budget policy.

Anxiety symptoms appear to be common among a portion of patients with chronic rhinosinusitis with nasal polyps.

A couple of Michigan residents have died due to cyclosporiasis complications, the first deaths associated with the current outbreak in the US.

Experts discuss the effect of spiritual practices, like meditation and religious service attendance, on substance misuse.

Fecal microbiota transplantation may offer short-term improvements in motor function and constipation severity for adults with Parkinson disease.

Restricting sugar in the first 1000 days following conception is associated with a lower risk for dementia later in life.

The American College of Chest Physicians offers 9 new conditional recommendations for the management of obstructive sleep apnea in pregnancy.

Heavy drinking, current alcohol use, and binge drinking prevalence among pregnant women in the US has increased from a low point in 2011.